Oncternal Therapeutics (NASDAQ:ONCT) Coverage Initiated by Analysts at StockNews.com
StockNews.com started coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Free Report) in a report released on Wednesday. The firm issued a hold rating on the stock. Oncternal Therapeutics Price Performance Shares of NASDAQ ONCT opened at $0.53 on Wednesday. The firm’s 50-day moving average price is $0.53 and its two-hundred day moving average price […]
More Stories
FEMA Confirms Acting Administrator Hamilton Has Been Replaced
By Jacob Burg Cameron Hamilton, acting administrator of the Federal Emergency Management Agency (FEMA), has been terminated and replaced, the...
Q4 EPS Estimates for Henry Schein Lowered by William Blair
Henry Schein, Inc. (NASDAQ:HSIC – Free Report) – William Blair cut their Q4 2025 EPS estimates for Henry Schein in...
MetLife Investment Management LLC Trims Stake in First Foundation Inc. (NASDAQ:FFWM)
MetLife Investment Management LLC reduced its stake in First Foundation Inc. (NASDAQ:FFWM – Free Report) by 15.7% during the fourth...
Hsbc Holdings PLC Raises Position in TrueBlue, Inc. (NYSE:TBI)
Hsbc Holdings PLC lifted its position in TrueBlue, Inc. (NYSE:TBI – Free Report) by 108.6% during the 4th quarter, HoldingsChannel...
Energy Services of America Co. (NASDAQ:ESOA) Shares Acquired by Susquehanna International Group LLP
Susquehanna International Group LLP boosted its holdings in Energy Services of America Co. (NASDAQ:ESOA – Free Report) by 950.6% during...
OPENLANE, Inc. (NYSE:KAR) Shares Sold by Price T Rowe Associates Inc. MD
Price T Rowe Associates Inc. MD cut its stake in shares of OPENLANE, Inc. (NYSE:KAR – Free Report) by 50.9%...